INO Inovio needs a new starter. It hasn't turned over a marketable product in its forty (40) years. Awful lot of ultra optimistic conjecture there, arcmo. I don't big pharma would give pump & dump, stock printing Inovio (INO) the time of day. Wouldn't want the association.